Eli Lilly Earnings, Revenue beat in Q4 By Investing.com

Eli Lilly (NYSE:LLY) reported on Friday fourth quarter earnings that beat analysts’ forecasts and revenue that topped expectations.

Eli Lilly announced earnings per share of $2.75 on revenue of $7.44B. Analysts polled by Investing.com anticipated EPS of $2.37 on revenue of $7.26B.

Eli Lilly shares are up 24% from the beginning of the year and are trading at $210.12 , down-from-52-week-high.They are outperforming the S&P 500 which is up 0.83% from the start of the year.

Eli Lilly follows other major Healthcare sector earnings this month

Eli Lilly’s report follows an earnings beat by J&J on Tuesday, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.83 on revenue of $21.69B.

Abbott Labs had beat expectations on Wednesday with fourth quarter EPS of $1.45 on revenue of $10.7B, compared to forecast for EPS of $1.35 on revenue of $9.94B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar